GW Pharmaceuticals Ltd.   Report issue

Contributed to NME For profit Phase 1 Phase 3 Phase 4
Founded: Cambridge United Kingdom (1998)
Status: Acquired by Jazz Pharmaceuticals (2021)

Organization Overview

First Clinical Trial
2001
NCT01610700
First Marketed Drug
2018
cannabidiol (Epidiolex)
First NDA Approval
2018
cannabidiol (Epidiolex)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GW Pharmaceuticals Ltd. | GW Pharma Ltd